Mindfulness-Oriented Recovery Enhancement Boosts Methadone Treatment

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 8, 2024.

By Lori Solomon HealthDay Reporter

MONDAY, Jan. 8, 2024 -- Telehealth-delivered mindfulness-oriented recovery enhancement (MORE) is a feasible and effective adjunct to methadone treatment (MT) for individuals with opioid use disorder (OUD) and pain, according to a study published online Dec. 7 in JAMA Psychiatry.

Nina A. Cooperman, Psy.D., from Rutgers Robert Wood Johnson Medical School in Piscataway, New Jersey, and colleagues evaluated the efficacy of MT as usual (usual care) versus telehealth MORE plus usual care among people with an OUD and pain. The analysis included 154 participants.

The researchers found that participants receiving MORE plus usual care had significantly less return to drug use (hazard ratio, 0.58) and MT dropout (hazard ratio, 0.41) than those receiving usual care in an adjusted analysis (e.g., methadone dose and recent drug use, at baseline). Participants receiving MORE plus usual care had significantly fewer days of any drug use (ratio of means, 0.58) than those receiving usual care only through 16 weeks, and a larger percentage maintained methadone adherence (95.5 versus 83.6 percent). MORE was also associated with significantly reduced depression scores and ecological momentary assessments of pain through 16-week follow-up. Anxiety scores increased in the usual care-only group and decreased in the MORE group, but the difference between groups did not reach significance.

"This randomized clinical trial demonstrated that telehealth MORE was a feasible adjunct to MT with significant effects on drug use, pain, depression, treatment retention, and adherence," the authors write.

Several authors disclosed ties to various institutions.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords